T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARD
1151
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $21.6M | ﹤0.01% |
1,010,522
+8,920
| +0.9% | +$192K |
|
1152
Visteon
VC
$2.84B
| $21.6M | ﹤0.01% |
174,620
+153,146
| +713% | +$17.4M |
|
|
HBI
1153
DELISTED
Hanesbrands
HBI
| $21.6M | ﹤0.01% |
876,796
-68,760
| -7% | -$1.65M |
|
1154
MakeMyTrip
MMYT
$5.67B
| $21.6M | ﹤0.01% |
750,794
-221,783
| -23% | -$7.09M |
|
|
SLCA
1155
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $21.6M | ﹤0.01% |
694,197
-85,455
| -11% | -$2.48M |
|
1156
Integer Holdings
ITGR
$4.25B
| $21.5M | ﹤0.01% |
419,365
-6,200
| -1% | -$284K |
|
1157
Synaptics
SYNA
$4.3B
| $21.4M | ﹤0.01% |
545,798
-16,235
| -3% | -$732K |
|
1158
United Therapeutics
UTHR
$21.9B
| $21.2M | ﹤0.01% |
181,155
+3,710
| +2% | +$474K |
|
1159
World Kinect Corp
WKC
$1.89B
| $21.2M | ﹤0.01% |
625,087
+13,691
| +2% | +$488K |
|
1160
Hubbell
HUBB
$27.1B
| $21.1M | ﹤0.01% |
182,241
+21,881
| +14% | +$2.51M |
|
|
CUB
1161
DELISTED
Cubic Corporation
CUB
| $21.1M | ﹤0.01% |
412,761
+168,190
| +69% | +$7.65M |
|
|
P
1162
Everpure Inc
P
$37B
| $21M | ﹤0.01% |
1,312,832
-13,200
| -1% | -$181K |
|
1163
CALL
J.M. Smucker
SJM
$12.7B
| $21M | ﹤0.01% |
+200,000
| New | +$22.8M |
|
1164
NetApp
NTAP
$39.6B
| $20.9M | ﹤0.01% |
478,703
-9,953
| -2% | -$411K |
|
1165
Hilltop Holdings
HTH
$2.25B
| $20.9M | ﹤0.01% |
804,950
+56,928
| +8% | +$1.43M |
|
|
NEX
1166
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $20.9M | ﹤0.01% |
1,253,358
+187,000
| +18% | +$2.74M |
|
1167
International Flavors & Fragrances
IFF
$21.4B
| $20.9M | ﹤0.01% |
145,983
-3,024
| -2% | -$415K |
|
1168
Team
TISI
$101M
| $20.9M | ﹤0.01% |
156,192
+14,041
| +10% | +$2.14M |
|
1169
Hasbro
HAS
$13.4B
| $20.8M | ﹤0.01% |
213,312
-3,773
| -2% | -$383K |
|
|
INST
1170
DELISTED
Instructure, Inc.
INST
| $20.8M | ﹤0.01% |
626,930
+8,410
| +1% | +$260K |
|
|
GBT
1171
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $20.7M | ﹤0.01% |
667,549
+111,723
| +20% | +$3.14M |
|
1172
ACI Worldwide
ACIW
$5.33B
| $20.6M | ﹤0.01% |
905,525
+75,915
| +9% | +$1.72M |
|
1173
Pultegroup
PHM
$24.6B
| $20.6M | ﹤0.01% |
753,630
-71,269
| -9% | -$1.8M |
|
|
XOXO
1174
DELISTED
Xo Group Inc
XOXO
| $20.6M | ﹤0.01% |
1,046,202
-180,160
| -15% | -$3.32M |
|
1175
Crocs
CROX
$6.26B
| $20.6M | ﹤0.01% |
2,119,880
+473,480
| +29% | +$4.05M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.